4
Changes in Ownership
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-23-004886
Director acquired 50,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
WILSON GLYNN · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-24 | Conversion : show line 1 in the form | +50,000 | 50,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-24 | Conversion : show line 2 in the form Convertible Promissory Note | −50,000 | 0 | D |
Loading xslF345X03/ownership.xml…